TABLE 3.
Frequency of responses to vaccine antigens by group
| Antigen | Response type | Result for regimena:
|
|||
|---|---|---|---|---|---|
| Day 0-14-28
|
Day 0-2-4-6
|
||||
| meCS6+ | meCS6− | meCS6+ | meCS6− | ||
| CS6 | IgA (feces) | 14 (50.4) | 21 (5.1) | 43 (8.2) | 40 (7.2) |
| IgA (serum) | 7 (4.4) | 0 (n/a)b | 14 (11.0) | 20 (15.0) | |
| IgG (serum) | 21 (3.9) | 0 (n/a) | 21 (4.6) | 27 (3.1) | |
| IgA-ASC | 86 (3.0) | 36 (1.7) | 57 (2.7) | 47 (2.5) | |
| LT | IgA (feces) | 50 (10.0) | 57 (8.3) | 71 (7.7) | 53 (6.0) |
| IgA (serum) | 57 (4.1) | 0 (n/a) | 36 (7.4) | 0 (n/a) | |
| IgG (serum) | 43 (9.7) | 7 (2.3) | 36 (5.4) | 0 (n/a) | |
| IgA-ASC | 71 (5.5) | 0 (n/a) | 57 (3.3) | 7 (2.3) | |
a
Serology responses are summarized as the percentages of volunteers meeting the responder definition and the median PFRs from the baseline titer among responders (in parentheses). ASC responses are summarized as the percentages of volunteers meeting the responder definition and the median maximum numbers of ASCs among responders (in parentheses). +, with adjuvant; −, without adjuvant.
b
n/a, not applicable.